Noucor

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Noucor - overview

Established

2021

Location

Barcelona, -, Spain

Primary Industry

Pharmaceuticals

About

Based in Barcelona, Spain, and founded in 2021, Noucor operates as a pharmaceutical company offering research and development, licensing, and contract manufacturing services. In January 2022, the firm’s minority stakes of 30% were acquired by MCH Private Equity. The firm as of April 2022, is led by its CEO, David Perdigó. The firm offers a range of pharmaceutical products and solutions in three primary business areas including generics, new chemical entities (NCE), and contract manufacturing.


Under Generics, Noucor develops active ingredients and complete dossiers for generic drugs, hence acting as a product co-development partner in the healthcare industry. Under NCE services, the firm offers developing and licensing solutions to NCEs as well as offers marketing and medical advice teams’ solutions across 70 countries. Under Contract Manufacturing services, Noucor provides facilities for solid and semi-solid product manufacturing.


Current Investors

MCH Private Equity

Primary Industry

Pharmaceuticals

Sub Industries

Pharmaceutical Research & Development

Website

www.noucor.com

Verticals

Manufacturing, RegTech

Company Stage

Mature - Buyout

Total Amount Raised

Subscriber access only

Noucor - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
BuyoutCompletedNoucor-

Displaying 1 - 1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.